Durvalumab Intravenous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Durvalumab Intravenous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Pneumococcal 13-valent conjugate vaccine
- Durvalumab Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Durvalumab Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Durvalumab Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Durvalumab Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Durvalumab Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Dutasteride
- Pms-Sodium Polystyrene Sulfonate-Dutasteride and tamsulosin
- Pms-Sodium Polystyrene Sulfonate-Dutasteride and Tamsulosin Capsules
- Pms-Sodium Polystyrene Sulfonate-Dutasteride Capsules
- Pms-Sodium Polystyrene Sulfonate-Dutoprol
- Pms-Sodium Polystyrene Sulfonate-Duvelisib